[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
Editorial
August 2016

Noninvasive Encapsulated Follicular Variant of Papillary Thyroid “Cancer” (or Not): Time for a Name Change

Author Affiliations
  • 1Department of Surgery, New York University Langone Medical Center, New York
  • 2Department of Biochemistry and Molecular Pharmacology, New York University Langone Medical Center, New York
  • 3Department of Otolaryngology, New York University Langone Medical Center, New York
JAMA Oncol. 2016;2(8):1005-1006. doi:10.1001/jamaoncol.2016.0714

Many subtypes of papillary thyroid cancer (PTC) have been described, of which classic PTC is the most common (70%-80%). The follicular variant of PTC (FVPTC) is the second most common subtype. It has increased in incidence by 4-fold in the last 3 decades, now making up approximately 20% of all thyroid cancers in Europe and North America.1,2

×